Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan

被引：11

作者：

Arashiro, Takeshi ^{[1
,2
,3
,4
]}

Arima, Yuzo ^{[1
]}

Kuramochi, Jin ^{[5
,6
]}

Muraoka, Hirokazu ^{[7
]}

Sato, Akihiro ^{[8
]}

Chubachi, Kumi ^{[9
]}

Yanai, Atsushi ^{[10
]}

Arioka, Hiroko ^{[10
]}

Uehara, Yuki ^{[11
,12
]}

Ihara, Genei ^{[13
]}

Kato, Yasuyuki ^{[14
]}

Yanagisawa, Naoki ^{[15
]}

Ueda, Akihiro ^{[16
]}

Kato, Hideaki ^{[17
]}

Oka, Hideaki ^{[18
]}

Nishida, Yusuke ^{[18
]}

Nidaira, Yuki ^{[5
]}

Asami, Takahiro ^{[19
]}

Jinta, Torahiko ^{[20
]}

Nakamura, Akira ^{[21
]}

Oba, Kunihiro ^{[22
]}

Taniyama, Daisuke ^{[23
]}

Yamamoto, Kei ^{[18
]}

Tanaka, Katsushi ^{[17
]}

Ueshima, Kankuro ^{[24
]}

Fuwa, Tetsuji ^{[24
]}

Stucky, Ashley ^{[1
]}

Suzuki, Tadaki ^{[2
]}

Smith, Chris ^{[3
]}

Hibberd, Martin ^{[3
]}

Ariyoshi, Koya ^{[4
]}

Suzuki, Motoi ^{[1
]}

机构：

[1] Natl Inst Infect Dis, Ctr Surveillance Immunizat & Epidemiol Res, Tokyo, Japan

[2] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan

[3] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England

[4] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan

[5] Kuramochi Clin Interpk, Tochigi, Japan

[6] Tokyo Med & Dent Univ, Dept Global Hlth Promot, Tokyo, Japan

[7] Clin TAMACHI, Tokyo, Japan

[8] KARADA Internal Med Clin, Tokyo, Japan

[9] Chubachi Internal Resp Med Clin, Tokyo, Japan

[10] St Lukes Int Hosp, Dept Gen Internal Med, Tokyo, Japan

[11] St Lukes Int Hosp, Dept Clin Lab, Tokyo, Japan

[12] Fujita Hlth Univ, Sch Med, Dept Infect Dis, Aichi, Japan

[13] Machida Ekimae Naika Clin, Tokyo, Japan

[14] Int Univ Hlth, Welf Narita Hosp, Dept Infect Dis, Chiba, Japan

[15] Yanagisawa Clin, Tokyo, Japan

[16] Japanese Red Cross Med Ctr, Dept Infect Dis, Tokyo, Japan

[17] Yokohama City Univ Med, Infect Prevent & Control Dept, Yokohama, Japan

[18] Saitama Med Ctr, Dept Gen Internal Med & Infect Dis, Saitama, Japan

[19] Sano Kosei Gen Hosp, Dept Internal Med, Tochigi, Japan

[20] St Lukes Int Hosp, Dept Pulm Med, Tokyo, Japan

[21] Asahi Gen Hosp, Dept Internal Med, Chiba, Japan

[22] Showa Gen Hosp, Dept Pediat, Tokyo, Japan

[23] Showa Gen Hosp, Dept Infect Dis, Tokyo, Japan

[24] NATURALI Co Ltd, Tokyo, Japan

来源：

OPEN FORUM INFECTIOUS DISEASES | 2023年 / 10卷 / 06期

关键词：

COVID-19; SARS-CoV-2; variants; test-negative design; vaccine effectiveness;

D O I：

10.1093/ofid/ofad240

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In this multicenter, prospective, test-negative, case-control study in Japan, the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent coronavirus disease 2019 mRNA vaccines against symptomatic infection during the BA.5-dominant period was high compared with no vaccination (65% and 76%) and moderate compared with monovalent vaccines administered over half a year earlier (46% combined). In this multi-center study in Japan, the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent vaccines against symptomatic infection during the BA.5-dominant period was high compared to no vaccination (65%/76%) and moderate compared to monovalent vaccines >6 months before (46% combined).

引用

页数：6

共 50 条

[31] Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients
Peled, Yael
Afek, Arnon
Patel, Jignesh K.
Raanani, Ehud
Segev, Amit
Ram, Eilon
Fardman, Alexander
Beigel, Roy
Atari, Nofar
Kliker, Limor
Abd Elkader, Bayan
Mandelboim, Michal
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (08): : 1054 - 1058
[32] Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Kimura, Izumi
Yamasoba, Daichi
Tamura, Tomokazu
Nao, Naganori
Suzuki, Tateki
Oda, Yoshitaka
Mitoma, Shuya
Ito, Jumpei
Nasser, Hesham
Zahradnik, Jiri
Uriu, Keiya
Fujita, Shigeru
Kosugi, Yusuke
Wang, Lei
Tsuda, Masumi
Kishimoto, Mai
Ito, Hayato
Suzuki, Rigel
Shimizu, Ryo
Begum, Mst Monira
Yoshimatsu, Kumiko
Kimura, Kanako Terakado
Sasaki, Jiei
Sasaki-Tabata, Kaori
Yamamoto, Yuki
Nagamoto, Tetsuharu
Kanamune, Jun
Kobiyama, Kouji
Asakura, Hiroyuki
Nagashima, Mami
Sadamasu, Kenji
Yoshimura, Kazuhisa
Shirakawa, Kotaro
Takaori-Kondo, Akifumi
Kuramochi, Jin
Schreiber, Gideon
Ishii, Ken J.
Hashiguchi, Takao
Ikeda, Terumasa
Saito, Akatsuki
Fukuhara, Takasuke
Tanaka, Shinya
Matsuno, Keita
Sato, Kei
CELL, 2022, 185 (21) : 3992 - +
[33] Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon, Aekkachai
Nutalai, Rungtiwa
Dijokaite-Guraliuc, Aiste
Zhou, Daming
Ginn, Helen M.
Selvaraj, Muneeswaran
Liu, Chang
Mentzer, Alexander J.
Supasa, Piyada
Duyvesteyn, Helen M. E.
Das, Raksha
Skelly, Donal
Ritter, Thomas G.
Amini, Ali
Bibi, Sagida
Adele, Sandra
Johnson, Sile Ann
Constantinides, Bede
Webster, Hermione
Temperton, Nigel
Klenerman, Paul
Barnes, Eleanor
Dunachie, Susanna J.
Crook, Derrick
Pollard, Andrew J.
Lambe, Teresa
Goulder, Philip
Paterson, Neil G.
Williams, Mark A.
Hall, David R.
Fry, Elizabeth E.
Huo, Jiandong
Mongkolsapaya, Juthathip
Ren, Jingshan
Stuart, David, I
Screaton, Gavin R.
CELL, 2022, 185 (14) : 2422 - +
[34] A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Chen, Zhe
Feng, Leilei
Wang, Lei
Zhang, Li
Zheng, Binyang
Fu, Hua
Li, Fengdi
Liu, Ligai
Lv, Qi
Deng, Ran
Xu, Yanli
Hu, Yongfeng
Zheng, Jianhua
Qin, Chuan
Bao, Linlin
Wang, Xiangxi
Jin, Qi
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
[35] Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
Huang, Zhuoying
Xu, Shuangfei
Liu, Jiechen
Wu, Linlin
Qiu, Jing
Wang, Nan
Ren, Jia
Li, Zhi
Guo, Xiang
Tao, Fangfang
Chen, Jian
Lu, Donglei
Sun, Xiaodong
Wang, Weibing
BMC MEDICINE, 2022, 20 (01)
[36] Protection against SARS-CoV-2 BA.4 and BA.5 subvariants via vaccination and natural infection: A modeling study
Okada, Yuta
Kayano, Taishi
Anzai, Asami
Zhang, Tong
Nishiura, Hiroshi
MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2023, 20 (02) : 2530 - 2543
[37] Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater
Wilhelm, Alexander
Agrawal, Shelesh
Schoth, Jens
Meinert-Berning, Christina
Bastian, Daniel
Orschler, Laura
Ciesek, Sandra
Teichgraeber, Burkhard
Wintgens, Thomas
Lackner, Susanne
Weber, Frank-Andreas
Widera, Marek
VIRUSES-BASEL, 2022, 14 (09):
[38] Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
Torres, Carolina
Nabaes Jodar, Mercedes
Acuna, Dolores
Zambrana Montano, Romina Micaela
Alberto Culasso, Andres Carlos
Fernando Amadio, Ariel
Aulicino, Paula
Ceballos, Santiago
Cacciabue, Marco
Debat, Humberto
Dus Santos, Maria Jose
Florencia Eberhardt, Maria
Espul, Carlos
Fay, Fabian
Ailen Fernandez, Maria
Fernandez, Franco
Fernandez Munoz, Juan Manuel
Ferrini, Florencia
Gallego, Fernando
Angelica Giri, Adriana
Cerri, Agustina
Bolatti, Elisa
Ines Gismondi, Maria
Goya, Stephanie
Gramundi, Ivan
Matias Irazoqui, Jose
Alberto Konig, Guido
Leiva, Viviana
Lucero, Horacio
Marquez, Nathalie
Nardi, Cristina
Ortiz, Belen
Pianciola, Luis
Beatriz Pintos, Carolina
Fabiana Puebla, Andrea
Victoria Rastellini, Carolina
Ezequiel Rojas, Alejandro
Sfalcin, Javier
Suarez, Ariel
Tittarelli, Estefania
Toro, Rosana
Vanina Villanova, Gabriela
Cecilia Ziehm, Maria
Carla Zimmermann, Maria
Zunino, Sebastian
Valinotto, Laura
Viegas, Mariana
VIRUSES-BASEL, 2023, 15 (02):
[39] Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
Zhuoying Huang
Shuangfei Xu
Jiechen Liu
Linlin Wu
Jing Qiu
Nan Wang
Jia Ren
Zhi Li
Xiang Guo
Fangfang Tao
Jian Chen
Donglei Lu
Xiaodong Sun
Weibing Wang
BMC Medicine, 20
[40] Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
Tegally, Houriiyah
Moir, Monika
Everatt, Josie
Giovanetti, Marta
Scheepers, Cathrine
Wilkinson, Eduan
Subramoney, Kathleen
Makatini, Zinhle
Moyo, Sikhulile
Amoako, Daniel G.
Baxter, Cheryl
Althaus, Christian L.
Anyaneji, Ugochukwu J.
Kekana, Dikeledi
Viana, Raquel
Giandhari, Jennifer
Lessells, Richard J.
Maponga, Tongai
Maruapula, Dorcas
Choga, Wonderful
Matshaba, Mogomotsi
Mbulawa, Mpaphi B.
Msomi, Nokukhanya
Naidoo, Yeshnee
Pillay, Sureshnee
Sanko, Tomasz Janusz
San, James E.
Scott, Lesley
Singh, Lavanya
Magini, Nonkululeko A.
Smith-Lawrence, Pamela
Stevens, Wendy
Dor, Graeme
Tshiabuila, Derek
Wolter, Nicole
Preiser, Wolfgang
Treurnicht, Florette K.
Venter, Marietjie
Chiloane, Georginah
McIntyre, Caitlyn
O'Toole, Aine
Ruis, Christopher
Peacock, Thomas P.
Roemer, Cornelius
Kosakovsky Pond, Sergei L.
Williamson, Carolyn
Pybus, Oliver G.
Bhiman, Jinal N.
Glass, Allison
Martin, Darren P.
NATURE MEDICINE, 2022, 28 (09) : 1785 - +

← 1 2 3 4 5 →